Published in Nucleic Acids Res on September 12, 1988
A phylogenetic analysis of the mycoplasmas: basis for their classification. J Bacteriol (1989) 6.66
A physical genome map of Pseudomonas aeruginosa PAO. EMBO J (1989) 2.60
Organization of the Haemophilus influenzae Rd genome. J Bacteriol (1989) 2.22
Analysis of three different repeated DNA elements present in the P1 operon of Mycoplasma pneumoniae: size, number and distribution on the genome. Nucleic Acids Res (1990) 2.21
New approaches for physical mapping of small genomes. J Bacteriol (1990) 1.94
Detection of Mycoplasma pneumoniae by polymerase chain reaction and nonradioactive hybridization in microtiter plates. J Clin Microbiol (1993) 1.91
Cloning of the complete Mycoplasma pneumoniae genome. Nucleic Acids Res (1989) 1.70
Application of molecular techniques to the study of hospital infection. Clin Microbiol Rev (2006) 1.57
Transposon mutagenesis reinforces the correlation between Mycoplasma pneumoniae cytoskeletal protein HMW2 and cytadherence. J Bacteriol (1997) 1.56
A physical map of the genome of Ureaplasma urealyticum 960T with ribosomal RNA loci. Nucleic Acids Res (1989) 1.45
The impact of two-dimensional pulsed-field gel electrophoresis techniques for the consistent and complete mapping of bacterial genomes: refined physical map of Pseudomonas aeruginosa PAO. Nucleic Acids Res (1991) 1.42
A spontaneous hemadsorption-negative mutant of Mycoplasma pneumoniae exhibits a truncated adhesin-related 30-kilodalton protein and lacks the cytadherence-accessory protein HMW1. J Bacteriol (1995) 1.38
Sequence divergence in the ORF6 gene of Mycoplasma pneumonia. J Bacteriol (1994) 1.36
Identification and complementation of frameshift mutations associated with loss of cytadherence in Mycoplasma pneumoniae. J Bacteriol (1999) 1.27
Physical analysis and mapping of the Mycoplasma pneumoniae chromosome. J Bacteriol (1990) 1.23
Genome size of Mycoplasma genitalium. J Bacteriol (1990) 1.22
A physical and genetic map of the Spiroplasma citri genome. Nucleic Acids Res (1992) 1.19
Sequence analysis of 56 kb from the genome of the bacterium Mycoplasma pneumoniae comprising the dnaA region, the atp operon and a cluster of ribosomal protein genes. Nucleic Acids Res (1996) 1.17
Physical map of the Brucella melitensis 16 M chromosome. J Bacteriol (1991) 1.10
Determination of microbial genome sizes by two-dimensional denaturing gradient gel electrophoresis. Nucleic Acids Res (1989) 1.08
Construction of an EcoRI restriction map of Mycoplasma pneumoniae and localization of selected genes. J Bacteriol (1992) 1.04
Multiple chromosomes in bacteria: structure and function of chromosome II of Rhodobacter sphaeroides 2.4.1T. J Bacteriol (1994) 1.04
Physical map of the genome of Acholeplasma oculi ISM1499 and construction of a Tn4001 derivative for macrorestriction chromosomal mapping. J Bacteriol (1994) 1.01
Characterization of a Mycoplasma pneumoniae hmw3 mutant: implications for attachment organelle assembly. J Bacteriol (2002) 0.99
Chromosome map of Xanthomonas campestris pv. campestris 17 with locations of genes involved in xanthan gum synthesis and yellow pigmentation. J Bacteriol (1999) 0.97
Construction of a chromosome map for the phage group II Staphylococcus aureus Ps55. J Bacteriol (1996) 0.77
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol (1977) 205.11
Studies on transformation of Escherichia coli with plasmids. J Mol Biol (1983) 116.81
Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res (1984) 86.56
A complementation analysis of the restriction and modification of DNA in Escherichia coli. J Mol Biol (1969) 71.21
Supercoil sequencing: a fast and simple method for sequencing plasmid DNA. DNA (1985) 40.01
Lambda replacement vectors carrying polylinker sequences. J Mol Biol (1983) 32.76
A simple method for DNA restriction site mapping. Nucleic Acids Res (1976) 22.24
Complete nucleotide sequence of bacteriophage T7 DNA and the locations of T7 genetic elements. J Mol Biol (1983) 19.98
Tissue cultures and mycoplasmas. Tex Rep Biol Med (1965) 17.31
Oligonucleotide probes complementary to variable regions of ribosomal RNA discriminate between Mycoplasma species. J Gen Microbiol (1987) 4.74
Mycoplasmas as agents of human disease. N Engl J Med (1981) 3.28
Total synthesis of a gene for bovine rhodopsin. Proc Natl Acad Sci U S A (1986) 3.08
Genome size of mycoplasmal DNA. Nature (1969) 2.86
Mycoplasmas (Mollicutes) have a low number of rRNA genes. J Bacteriol (1984) 2.62
Transposition of gram-positive transposon Tn916 in Acholeplasma laidlawii and Mycoplasma pulmonis. Science (1987) 1.96
Conjugal transfer of transposon Tn916 from Streptococcus faecalis to Mycoplasma hominis. J Bacteriol (1987) 1.84
Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae. Nucleic Acids Res (1996) 10.46
Conversion of bacteriophage fd into an efficient single-stranded DNA vector system. Mol Gen Genet (1980) 3.57
Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev Cell (2001) 3.29
Transposition of a DNA sequence determining kanamycin resistance into the single-stranded genome of bacteriophage fd. Mol Gen Genet (1978) 3.19
Re-annotating the Mycoplasma pneumoniae genome sequence: adding value, function and reading frames. Nucleic Acids Res (2000) 2.79
5-Fluorouracil in colorectal cancer, a never ending story. Ann Oncol (1996) 2.69
Deoxyribonucleic acid replication in vitro. J Mol Biol (1972) 2.64
Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet (2001) 2.45
Gene dosage by quantitative real-time PCR. Biotechniques (1999) 2.45
Isolation and characterization of thermosensitive Escherichia coli mutants defective in deoxyribonucleic acid replication. J Bacteriol (1973) 2.38
Comparative analysis of the genomes of the bacteria Mycoplasma pneumoniae and Mycoplasma genitalium. Nucleic Acids Res (1997) 2.28
Analysis of three different repeated DNA elements present in the P1 operon of Mycoplasma pneumoniae: size, number and distribution on the genome. Nucleic Acids Res (1990) 2.21
Repetitive DNA sequences in Mycoplasma pneumoniae. Nucleic Acids Res (1988) 2.09
A randomized study of high-dose cytarabine in induction in acute myeloid leukemia. Blood (1996) 2.06
Gastrointestinal involvement in non-Hodgkin's lymphoma. Cancer (1980) 1.82
Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled study. Ann Oncol (1998) 1.80
Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO). Ann Oncol (2000) 1.79
Cloning of the complete Mycoplasma pneumoniae genome. Nucleic Acids Res (1989) 1.70
Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation. Bone Marrow Transplant (2005) 1.64
Overview of monoclonal antibodies in cancer therapy: present and promise. Crit Rev Oncol Hematol (2005) 1.63
Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Warburg syndrome. J Med Genet (2004) 1.56
Transposon mutagenesis reinforces the correlation between Mycoplasma pneumoniae cytoskeletal protein HMW2 and cytadherence. J Bacteriol (1997) 1.56
The proline-rich P65 protein of Mycoplasma pneumoniae is a component of the Triton X-100-insoluble fraction and exhibits size polymorphism in the strains M129 and FH. J Bacteriol (1995) 1.54
Identification and characterization of hitherto unknown Mycoplasma pneumoniae proteins. Mol Microbiol (1994) 1.51
The JAK2 V617F mutation is detectable in granulocyte populations at greater than two copies per cell among individuals with myeloproliferative disorders. Leukemia (2007) 1.47
Yttrium-90 DOTATOC: first clinical results. Eur J Nucl Med (1999) 1.46
Transcription profiles of the bacterium Mycoplasma pneumoniae grown at different temperatures. Nucleic Acids Res (2003) 1.42
Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC): a phase I/II trial. Ann Oncol (2010) 1.40
The 'positive-inside rule' applies to thylakoid membrane proteins. FEBS Lett (1991) 1.40
Training aboriginal health care professionals in Manitoba. CMAJ (2000) 1.39
Nucleotide sequence of the 16S rRNA of Mycoplasma hyopneumoniae. Nucleic Acids Res (1987) 1.37
Organization of the ribosomal RNA genes in Mycoplasma hyopneumoniae: the 5S rRNA gene is separated from the 16S and 23S rRNA genes. Mol Gen Genet (1986) 1.36
Sequence divergence in the ORF6 gene of Mycoplasma pneumonia. J Bacteriol (1994) 1.36
Transcription in Mycoplasma pneumoniae. Nucleic Acids Res (2000) 1.34
Yttrium-90-labelled somatostatin-analogue for cancer treatment. Lancet (1998) 1.34
Surface proteins of Mycoplasma hyopneumoniae identified from an Escherichia coli expression plasmid library. Infect Immun (1985) 1.28
Identification and complementation of frameshift mutations associated with loss of cytadherence in Mycoplasma pneumoniae. J Bacteriol (1999) 1.27
Identification of gene products of the P1 operon of Mycoplasma pneumoniae. Mol Microbiol (1991) 1.26
Analysis of transcription and processing signals of the 16S-23S rRNA operon of Mycoplasma hyopneumoniae. Mol Gen Genet (1986) 1.25
The international quality requirements for the conduct of clinical studies and the challenges for study centers to implement them. Ann Oncol (2004) 1.23
Spatial arrangement of gene products of the P1 operon in the membrane of Mycoplasma pneumoniae. Infect Immun (1994) 1.22
Localization and biochemical characterization of the ORF6 gene product of the Mycoplasma pneumoniae P1 operon. Infect Immun (1992) 1.22
The P200 protein of Mycoplasma pneumoniae shows common features with the cytadherence-associated proteins HMW1 and HMW3. Gene (1996) 1.20
A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity. Ann Oncol (2005) 1.20
Defining the mycoplasma 'cytoskeleton': the protein composition of the Triton X-100 insoluble fraction of the bacterium Mycoplasma pneumoniae determined by 2-D gel electrophoresis and mass spectrometry. Microbiology (2001) 1.19
Sequence analysis of 56 kb from the genome of the bacterium Mycoplasma pneumoniae comprising the dnaA region, the atp operon and a cluster of ribosomal protein genes. Nucleic Acids Res (1996) 1.17
Laminin alpha2 chain-deficient congenital muscular dystrophy: variable epitope expression in severe and mild cases. Neurology (1998) 1.16
Release from a human monocyte-like cell line of two different soluble forms of the lipopolysaccharide receptor, CD14. Eur J Immunol (1993) 1.15
The subunit b of the F0F1-type ATPase of the bacterium Mycoplasma pneumoniae is a lipoprotein. J Biol Chem (1998) 1.15
Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy. Oncology (2003) 1.14
5-Fluorouracil, 4-epidoxorubicin, and mitomycin C (FEM) combination chemotherapy for advanced gastric carcinoma. A phase-II trial by the "chemotherapiegruppe gastrointestinaler tumoren (CGT)". Onkologie (1987) 1.14
Synthesis of a small, cysteine-rich, 29 amino acids long peptide in Mycoplasma pneumoniae. FEMS Microbiol Lett (2005) 1.14
The configuration of fibrin clots determines capillary morphogenesis and endothelial cell migration. Microvasc Res (1996) 1.12
Codon reading scheme in Mycoplasma pneumoniae revealed by the analysis of the complete set of tRNA genes. Nucleic Acids Res (1993) 1.12
Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines. AIDS (1992) 1.11
Comparative analysis of the complete genome sequences of Helicoverpa zea and Helicoverpa armigera single-nucleocapsid nucleopolyhedroviruses. J Gen Virol (2002) 1.10
Recombinant human erythropoietin in patients with myelodysplastic syndrome and myelofibrosis. Acta Haematol (1993) 1.08
Towards a two-dimensional proteome map of Mycoplasma pneumoniae. Electrophoresis (2000) 1.08
SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer. Br J Cancer (2002) 1.08
Sequence analysis and characterization of the hmw gene cluster of Mycoplasma pneumoniae. Gene (1996) 1.06
Interaction between light harvesting chlorophyll-a/b protein (LHCII) kinase and cytochrome b6/f complex. In vitro control of kinase activity. J Biol Chem (1990) 1.06
CD14 and tolerance to lipopolysaccharide: biochemical and functional analysis. Immunology (1993) 1.05
Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study. J Clin Oncol (2001) 1.04
Construction of an EcoRI restriction map of Mycoplasma pneumoniae and localization of selected genes. J Bacteriol (1992) 1.04
Veno-occlusive disease of the liver induced by gemcitabine. Ann Oncol (1998) 1.03
Cellular localization of Nef expressed in persistently HIV-1-infected low-producer astrocytes. AIDS (1992) 1.03
Estimation of the environmental contamination by phthalic acid esters leaching from household wastes. Sci Total Environ (1997) 1.02
Diagnosis and treatment of intravascular lymphomatosis. Arch Neurol (2000) 1.02
Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study Group. J Clin Oncol (1998) 1.00
Enteropathy-associated T-cell lymphoma with initial manifestation in the CNS. Neurology (2003) 1.00
Activity and stability of a thermostable alpha-amylase compared to its mesophilic homologue: mechanisms of thermal adaptation. Biochemistry (2001) 0.99
Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment. Cancer Res (1988) 0.99
Autosomal dominant distal myopathy: further evidence of a chromosome 14 locus. Neuromuscul Disord (2001) 0.98
A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer. Hum Gene Ther (1998) 0.98
A plant lectin derived from Viscum album induces cytokine gene expression and protein production in cultures of human peripheral blood mononuclear cells. Nat Immun (1995) 0.97
Direct effects of recombinant nuclear polyhedrosis viruses on selected nontarget organisms. J Econ Entomol (1995) 0.97
Nucleotide sequence of the bacteriophage T4 gene 57 and a deduced amino acid sequence. Nucleic Acids Res (1982) 0.97
Autosomal dominant transmission of GLUT1 deficiency. Hum Mol Genet (2001) 0.96
Specific demonstration of drug-induced tumour cell apoptosis in human xenografts models using a plasma biomarker. Cancer Biomark (2009) 0.95
Initial experience with a new balloon-guided single lead catheter for internal cardioversion of atrial fibrillation and dual chamber pacing. Pacing Clin Electrophysiol (1999) 0.95
Position specificity of Ki-ras oncogene mutations during the progression of colorectal carcinoma. Oncology (1993) 0.94
Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: long-term results of a randomized trial of radiotherapy alone. J Clin Oncol (2001) 0.93
Pamidronate reduces bone loss after allogeneic stem cell transplantation. J Clin Endocrinol Metab (2006) 0.93
An x-ray small angle study of the bacteriophages fr and R17. Eur J Biochem (1971) 0.93
Guided migration as a novel mechanism of capillary network remodeling is regulated by basic fibroblast growth factor. Histochem Cell Biol (1998) 0.92
X-linked dilated cardiomyopathy. Novel mutation of the dystrophin gene. Ann N Y Acad Sci (1995) 0.91
Rapid iron infusion with iron polymaltose: further improvements may be possible. Intern Med J (2012) 0.91
Identification of a small RNA within the pdh gene cluster of Mycoplasma pneumoniae and Mycoplasma genitalium. J Bacteriol (2000) 0.91
The influence of histologic type on the incidence and duration of response in non-Hodgkin's lymphoma. Cancer (1982) 0.91
Assembly of bacteriophage T4 tail fibers: identification and characterization of the nonstructural protein gp57. Mol Gen Genet (1981) 0.91
Overexpression and amplification of c-myc during progression of human colorectal cancer. Oncology (1997) 0.90
Contact-dependent inhibition of angiogenesis by cardiac fibroblasts in three-dimensional fibrin gels in vitro: implications for microvascular network remodeling and coronary collateral formation. Cell Tissue Res (1998) 0.90
[The question of cell membranes in desmidiales. The role of Ca in cell membrane restitution]. Protoplasma (1966) 0.90
Gene expression analysis by a competitive and differential PCR with antisense competitors. Biotechniques (1994) 0.90
Secondary reduction of alpha7B integrin in laminin alpha2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle. J Neurol Sci (1999) 0.90
The thioredoxin reductase system of mycoplasmas. Microbiology (1997) 0.90
Genetic analysis of T4 tail fiber assembly. II. Bacterial host mutants that allow bypass of T4 gene 57 function. Virology (1976) 0.89